| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500382 | Farmacia Hospitalaria | 2009 | 8 Pages |
Abstract
The results of the study indicate that the application of a pharmaceutical care model based on the prospective validation of drugs with renal risk, very significantly improved the adaptation of dosing regimens in kidney disease.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
L. Álvarez Arroyo, E. Climent Grana, N. Bosacoma Ros, S. Roca Meroño, M. Perdiguero Gil, J.P. Ordovás Baines, J. Sánchez Payá,